Seroatlas · Human Serome Atlas

BCS1L

Mitochondrial chaperone BCS1

Also known as: BCS, BCS1_HUMAN, BJS, h-BCS, Hs.6719

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9Y276
Gene
BCS1L
Ensembl
ENSG00000074582
Chromosome
2
Canonical length
419 aa
Protein class
Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
Subcellular location
Vesicles,Mid piece

OverviewNCBI Gene

This gene encodes a homolog of the S. cerevisiae bcs1 protein which is involved in the assembly of complex III of the mitochondrial respiratory chain. The encoded protein does not contain a mitochondrial targeting sequence but experimental studies confirm that it is imported into mitochondria. Mutations in this gene are associated with mitochondrial complex III deficiency and the GRACILE syndrome. Several alternatively spliced transcripts encoding two different isoforms have been described. [provided by RefSeq, Jan 2016]

Canonical amino-acid sequenceUniProt

419 residues, UniProt reviewed canonical sequence.

>Q9Y276|BCS1L
     1  MPLSDFILAL KDNPYFGAGF GLVGVGTALA LARKGVQLGL VAFRRHYMIT LEVPARDRSY
    61  AWLLSWLTRH STRTQHLSVE TSYLQHESGR ISTKFEFVPS PGNHFIWYRG KWIRVERSRE
   121  MQMIDLQTGT PWESVTFTAL GTDRKVFFNI LEEARELALQ QEEGKTVMYT AVGSEWRPFG
   181  YPRRRRPLNS VVLQQGLADR IVRDVQEFID NPKWYTDRGI PYRRGYLLYG PPGCGKSSFI
   241  TALAGELEHS ICLLSLTDSS LSDDRLNHLL SVAPQQSLVL LEDVDAAFLS RDLAVENPVK
   301  YQGLGRLTFS GLLNALDGVA STEARIVFMT TNHVDRLDPA LIRPGRVDLK EYVGYCSHWQ
   361  LTQMFQRFYP GQAPSLAENF AEHVLRATNQ ISPAQVQGYF MLYKNDPVGA IHNAESLRR

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against BCS1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.33
Highest tissue expression
40 nTPM

Expression across tissuesHPA

Tissue

  • pancreas: 40 nTPM
  • liver: 40 nTPM
  • heart muscle: 39 nTPM
  • kidney: 33 nTPM
  • skeletal muscle: 31 nTPM
  • adrenal gland: 29 nTPM

Single-cell type

  • cardiomyocytes: 48 nCPM
  • esophageal basal cells: 43 nCPM
  • cytotrophoblasts: 38 nCPM
  • esophageal suprabasal cells: 33 nCPM
  • oocytes: 32 nCPM
  • decidual stromal cells: 30 nCPM

Immune cell

  • myeloid DC: 25 nTPM
  • basophil: 20 nTPM
  • plasmacytoid DC: 14 nTPM
  • memory B-cell: 14 nTPM
  • T-reg: 13 nTPM
  • naive B-cell: 13 nTPM

Brain region

  • white matter: 19 nTPM
  • pons: 19 nTPM
  • midbrain: 18 nTPM
  • medulla oblongata: 17 nTPM
  • cerebellum: 17 nTPM
  • hypothalamus: 17 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about BCS1L.

Disease | AllUniProt

Conditions BCS1L is implicated in, by any mechanism.

Disease | GeneticClinVar

140 pathogenic / likely-pathogenic of 603 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.24
gnomAD pLI
0
gnomAD missense Z
1.62
DepMap mean gene effect
-0.38
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of BCS1L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads BCS1L as an antibody target. Whether an autoantibody or antibody against BCS1L could matter depends on whether native BCS1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

BCS1L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label BCS1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/BCS1L. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...